FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2183634351> ?p ?o ?g. }

• W2183634351 endingPage "298" @default.
• W2183634351 startingPage "291" @default.
• W2183634351 abstract "Local treatment of unresectable tumors is challenging, particularly with radioactivity. Current practice relies on external beam irradiation or on a variety of medical devices for brachytherapy. Both approaches proved useful in controlling tumor growth, but are characterized by poor compliance of the patient, significant side-effects, high costs, and technological complexity, which hamper widespread use. The authors recently described a novel form of radionuclide therapy based on the oxidized form of avidin that, chemically reacting with tissue proteins, can secure radioactive biotin within the injected tissue, either when precomplexed or when taken from the blood stream after intravenous administration. AvidinOX-pretargeted (177)Lu-biotinDOTA ((177)Lu-ST2210) is currently under clinical investigation for the treatment of liver oligometastases from colorectal cancer (clinicaltrials.gov/NCT02053324). In the present work, the authors show that injected AvidinOX can link tissues of various natures such as prostate, kidney, breast, or brain and can react by contact with scraped tissues such as skin or urinary bladder. AvidinOX injected into human OSC19 tongue cancer masses orthotopically transplanted in nude mice takes up intravenously administered (90)Y-ST2210, which exerts significant antitumor activity, while preserving the integrity and functionality of the tongue. Present data confirm that AvidinOX-based radionuclide therapy is an innovative and promising approach for the local treatment of inoperable tumors." @default.
• W2183634351 created "2016-06-24" @default.
• W2183634351 creator A5010097454 @default.
• W2183634351 creator A5011237039 @default.
• W2183634351 creator A5026780110 @default.
• W2183634351 creator A5033537079 @default.
• W2183634351 creator A5041018718 @default.
• W2183634351 creator A5044611652 @default.
• W2183634351 creator A5047112366 @default.
• W2183634351 creator A5078685159 @default.
• W2183634351 date "2015-09-01" @default.
• W2183634351 modified "2023-10-17" @default.
• W2183634351 title "Radionuclide Therapy of Unresectable Tumors with AvidinOX and ⁹⁰Y-biotinDOTA: Tongue Cancer Paradigm" @default.
• W2183634351 cites W136971731 @default.
• W2183634351 cites W1678810018 @default.
• W2183634351 cites W1969290748 @default.
• W2183634351 cites W2002906850 @default.
• W2183634351 cites W2006101847 @default.
• W2183634351 cites W2009540913 @default.
• W2183634351 cites W2010279439 @default.
• W2183634351 cites W2024825825 @default.
• W2183634351 cites W2028035236 @default.
• W2183634351 cites W2031743921 @default.
• W2183634351 cites W2032888414 @default.
• W2183634351 cites W2039664986 @default.
• W2183634351 cites W2048596113 @default.
• W2183634351 cites W2055978840 @default.
• W2183634351 cites W2061436674 @default.
• W2183634351 cites W2066397665 @default.
• W2183634351 cites W2071749637 @default.
• W2183634351 cites W2082870228 @default.
• W2183634351 cites W2090883361 @default.
• W2183634351 cites W2112623012 @default.
• W2183634351 cites W2155304401 @default.
• W2183634351 cites W2245165475 @default.
• W2183634351 cites W2460472718 @default.
• W2183634351 doi "https://doi.org/10.1089/cbr.2015.1837" @default.
• W2183634351 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4575534" @default.
• W2183634351 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26167947" @default.
• W2183634351 hasPublicationYear "2015" @default.
• W2183634351 type Work @default.
• W2183634351 sameAs 2183634351 @default.
• W2183634351 citedByCount "10" @default.
• W2183634351 countsByYear W21836343512015 @default.
• W2183634351 countsByYear W21836343512017 @default.
• W2183634351 countsByYear W21836343512018 @default.
• W2183634351 countsByYear W21836343512019 @default.
• W2183634351 countsByYear W21836343512020 @default.
• W2183634351 countsByYear W21836343512022 @default.
• W2183634351 countsByYear W21836343512023 @default.
• W2183634351 crossrefType "journal-article" @default.
• W2183634351 hasAuthorship W2183634351A5010097454 @default.
• W2183634351 hasAuthorship W2183634351A5011237039 @default.
• W2183634351 hasAuthorship W2183634351A5026780110 @default.
• W2183634351 hasAuthorship W2183634351A5033537079 @default.
• W2183634351 hasAuthorship W2183634351A5041018718 @default.
• W2183634351 hasAuthorship W2183634351A5044611652 @default.
• W2183634351 hasAuthorship W2183634351A5047112366 @default.
• W2183634351 hasAuthorship W2183634351A5078685159 @default.
• W2183634351 hasBestOaLocation W21836343512 @default.
• W2183634351 hasConcept C121608353 @default.
• W2183634351 hasConcept C126322002 @default.
• W2183634351 hasConcept C142724271 @default.
• W2183634351 hasConcept C2776235491 @default.
• W2183634351 hasConcept C2777416452 @default.
• W2183634351 hasConcept C2779744641 @default.
• W2183634351 hasConcept C2780192828 @default.
• W2183634351 hasConcept C2781074409 @default.
• W2183634351 hasConcept C2989005 @default.
• W2183634351 hasConcept C2993559085 @default.
• W2183634351 hasConcept C502942594 @default.
• W2183634351 hasConcept C509974204 @default.
• W2183634351 hasConcept C71924100 @default.
• W2183634351 hasConceptScore W2183634351C121608353 @default.
• W2183634351 hasConceptScore W2183634351C126322002 @default.
• W2183634351 hasConceptScore W2183634351C142724271 @default.
• W2183634351 hasConceptScore W2183634351C2776235491 @default.
• W2183634351 hasConceptScore W2183634351C2777416452 @default.
• W2183634351 hasConceptScore W2183634351C2779744641 @default.
• W2183634351 hasConceptScore W2183634351C2780192828 @default.
• W2183634351 hasConceptScore W2183634351C2781074409 @default.
• W2183634351 hasConceptScore W2183634351C2989005 @default.
• W2183634351 hasConceptScore W2183634351C2993559085 @default.
• W2183634351 hasConceptScore W2183634351C502942594 @default.
• W2183634351 hasConceptScore W2183634351C509974204 @default.
• W2183634351 hasConceptScore W2183634351C71924100 @default.
• W2183634351 hasIssue "7" @default.
• W2183634351 hasLocation W21836343511 @default.
• W2183634351 hasLocation W21836343512 @default.
• W2183634351 hasLocation W21836343513 @default.
• W2183634351 hasLocation W21836343514 @default.
• W2183634351 hasOpenAccess W2183634351 @default.
• W2183634351 hasPrimaryLocation W21836343511 @default.
• W2183634351 hasRelatedWork W2002769163 @default.
• W2183634351 hasRelatedWork W2010020620 @default.
• W2183634351 hasRelatedWork W2023503398 @default.
• W2183634351 hasRelatedWork W2027294118 @default.
• W2183634351 hasRelatedWork W2139928071 @default.

• next